Meiji Yasuda Asset Management Co Ltd. Purchases 228 Shares of Mettler-Toledo International, Inc. $MTD

Key Points

• Meiji Yasuda Asset Management Co Ltd. increased its holdings in Mettler-Toledo International by 11.5% during the first quarter, bringing its total investment to approximately $2.62 million.
• Other institutional investors also raised their stakes in Mettler-Toledo International, with notable increases from Vanguard Group (1.2%) and AllianceBernstein L.P. (21.6%).
• Mettler-Toledo International recently reported $10.09 earnings per share for the quarter, exceeding analysts' expectations, and set FY 2025 guidance at 42.100-42.600 EPS.

Meiji Yasuda Asset Management Co Ltd. increased its position in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 11.5% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,215 shares of the medical instruments supplier's stock after purchasing an additional 228 shares during the period. Meiji Yasuda Asset Management Co Ltd.'s holdings in Mettler-Toledo International were worth $2,616,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of MTD. WPG Advisers LLC bought a new stake in shares of Mettler-Toledo International during the 1st quarter valued at $41,000. Zions Bancorporation National Association UT bought a new stake in shares of Mettler-Toledo International during the 1st quarter valued at $43,000. Golden State Wealth Management LLC raised its position in shares of Mettler-Toledo International by 583.3% during the 1st quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier's stock valued at $48,000 after purchasing an additional 35 shares during the period. Menard Financial Group LLC bought a new stake in shares of Mettler-Toledo International during the 4th quarter valued at $67,000. Finally, Blue Trust Inc. raised its position in shares of Mettler-Toledo International by 520.0% during the 1st quarter. Blue Trust Inc. now owns 62 shares of the medical instruments supplier's stock valued at $73,000 after purchasing an additional 52 shares during the period. 95.07% of the stock is currently owned by institutional investors.

Insider Activity at Mettler-Toledo International

In related news, Director Thomas P. Salice sold 1,062 shares of Mettler-Toledo International stock in a transaction dated Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the completion of the sale, the director owned 283 shares in the company, valued at $368,154.70. This trade represents a 78.96% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Shawn Vadala sold 300 shares of Mettler-Toledo International stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $1,325.00, for a total transaction of $397,500.00. Following the sale, the chief financial officer owned 5,095 shares of the company's stock, valued at $6,750,875. The trade was a 5.56% decrease in their position. The disclosure for this sale can be found here. Insiders sold 1,827 shares of company stock worth $2,371,208 in the last 90 days. 0.77% of the stock is owned by corporate insiders.

Mettler-Toledo International Stock Performance

Shares of NYSE:MTD traded down $24.66 on Friday, reaching $1,258.06. The company's stock had a trading volume of 109,047 shares, compared to its average volume of 118,112. The company has a 50-day simple moving average of $1,258.94 and a 200 day simple moving average of $1,184.82. The company has a market cap of $25.92 billion, a P/E ratio of 31.86, a PEG ratio of 3.78 and a beta of 1.37. Mettler-Toledo International, Inc. has a 52-week low of $946.69 and a 52-week high of $1,521.01.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, beating analysts' consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The company had revenue of $983.22 million during the quarter, compared to analyst estimates of $957.41 million. During the same quarter last year, the business posted $9.65 EPS. The firm's revenue for the quarter was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, equities research analysts forecast that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

MTD has been the topic of several recent analyst reports. Barclays initiated coverage on shares of Mettler-Toledo International in a research report on Tuesday, June 24th. They set an "overweight" rating and a $1,325.00 price objective on the stock. Citigroup raised their target price on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a "buy" rating in a research note on Thursday, August 21st. Robert W. Baird raised their target price on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a "neutral" rating in a research note on Monday, August 4th. Bank of America raised their target price on shares of Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the company a "neutral" rating in a research note on Thursday, June 26th. Finally, UBS Group raised shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and cut their target price for the company from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th. Five equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $1,311.11.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.